Legendary licenses

Scienmag

Licensing expert Bob Westervelt, who has worked to transfer Sandia National Laboratories technologies in the medical, solar and hydrogen production fields, received the 2021 Outstanding Technology Transfer Professional Award from the Federal Laboratory Consortium.

Biogen licenses a stroke drug from Japanese drugmaker TMS

Bio Pharma Dive

The drug, which Biogen had an option to license, is one of two in the biotech's pipeline for a condition that has had few new treatments developed

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Ignis Health licenses telehealth roadmap from the Medical University of South Carolina

Scienmag

Technology and Engineering Biotechnology Health Care Systems/Services Health Professionals Information Management/Tracking Systems Licenses/Patents Management Science/Operations Research Medicine/Health Technology Transfer Telecommunications

Akili adds to ADHD gaming range with £37m TALi licensing deal

Pharma Phorum

Akili already has the first and only FDA cleared video game-based digital therapeutic (DTx) for children with attention-deficit hyperactivity disorder (ADHD), but is looking to add to its range via a licensing deal with Australia’s TALi Digital. .

ERS Genomics and Cellular Engineering Technologies Enter CRISPR/Cas9 License Agreement

BioTech 365

Heritage Granted Health Canada Research License

BioTech 365

Heritage Granted Health Canada Research License Heritage Granted Health Canada Research License TORONTO–(BUSINESS WIRE)–Heritage Cannabis Holdings Corp.

Avacta Signs Diagnostic Licensing Deal with Biokit

BioTech 365

The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation

Scienmag

Bill & Melinda Gates Medical Research Institute to develop formulation -AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES- LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement […].

ERS Genomics and Nippon Gene sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and Japan SLC Sign CRISPR/Cas9 License Agreement

BioTech 365

ERS Genomics signs CRISPR license agreement with Otsuka

Pharma Times

License grants Otsuka access to CRISPR/Cas9 genome editing technology

BeiGene Announces U.S. FDA Acceptance of Biologics License Application for Tislelizumab in Esophageal Squamous Cell Carcinoma

BioTech 365

FDA Acceptance of Biologics License Application for Tislelizumab in Esophageal Squamous Cell Carcinoma BeiGene Announces U.S. BeiGene Announces U.S.

Sierra Oncology licenses myelofibrosis candidate from AstraZeneca

Pharma Times

Planned Phase II study to combine the BET inhibitor with momelotinib

CARDIOGENICS HOLDINGS INC. ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION

BioTech 365

ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION CARDIOGENICS HOLDINGS INC. ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION Caledon, Ontario, Sept. CARDIOGENICS HOLDINGS INC. 03, 2021 (GLOBE NEWSWIRE) — CardioGenics Holdings Inc. OTC PINK: CGNH) (the “Company”)announced today that its subsidiary, CardioGenics Inc. CardioGenics”), has … Continue reading → GlobeNewswire

BMS Licenses IL-12 from Dragonfly in $475 Million Deal

BioSpace

Bristol Myers Squibb plunked down $475 million for the exclusive license to Dragonfly Therapeutics’ interleukin-12 (IL-12) investigational immunotherapy program

AM-Pharma and Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan

BioTech 365

AM-Pharma and Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan AM-Pharma and Kyowa Kirin Sign Exclusive License Agreement for Commercialization of Ilofotase Alfa in Japan AM-Pharma to receive EUR 20 million upfront payment, and EUR … Continue reading → Business Wire

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement

BioTech 365

ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement ERS Genomics and GenScript Biotech Corporation sign CRISPR/Cas9 license agreement License agreement to enhance GenScript’s CRISPR offering for gene and cell therapy research DUBLIN & PISCATAWAY, N.J.–(BUSINESS

Gene 52

Lilly adds to pain pipeline with Asahi Kasei licensing deal

Pharma Phorum

US drugmaker Eli Lilly – still waiting for an FDA decision on one non-opioid pain drug – has just added another to its pipeline via a licensing agreement with Japan’s Asahi Kasei worth up to $410 million. The post Lilly adds to pain pipeline with Asahi Kasei licensing deal appeared first on.

Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use

BioTech 365

Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use Roswell Park Comprehensive Cancer Center Licenses Invivoscribe’s LymphoTrack Software for Plug and Play Pipeline Use SAN DIEGO–(BUSINESS WIRE)–#invivoscribe–Invivoscribe, Inc.,

Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand

BioTech 365

Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand Sparsentan is … Continue reading → Business Wire

Seagen and RemeGen Announce Exclusive Worldwide License and Co-Development Agreement for Disitamab Vedotin

BioTech 365

Proteros Enters Into Oncology Collaboration and License Agreement With AstraZeneca

BioTech 365

Cytiva licenses Allen Institute’s advanced machine learning technology

Scienmag

Strategic license to advance the field of 3D and live cell imaging Credit: Allen Institute Cytiva and the Allen Institute have entered into a license agreement to integrate the Allen Institute’s machine learning technology with Cytiva’s microscopy and image analysis systems to advance the development of cell imaging innovations.

Curio Wellness Secures Industry-leading Franchisor License, Accepting Franchise and Investment Fund Applications in States Nationwide

BioTech 365

RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.

BioTech 365

RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc. RubrYc Therapeutics Announces Series A2 Preferred Equity Financing, Collaboration, and RTX-003 License with iBio, Inc.

ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical

BioTech 365

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research

BioTech 365

Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Hubrecht Institute Licenses Flow Eighteen38 Reagent Antibodies for Cancer Research Antibodies generated by Flow Eighteen38 to be used as research tools by Hubrecht Institute.

Tampa FL Institute of Interpersonal Hypnotherapy Licensed Hypnosis Training

BioTech 365

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer

BioTech 365

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer CAMBRIDGE, Mass. &

GATC Health Licenses Diabetes Platform to GATC DB Care Corp

BioTech 365

GATC Health Licenses Diabetes Platform to GATC DB Care Corp GATC Health Licenses Diabetes Platform to GATC DB Care Corp Dr. Jonathan Lakey to oversee research and product development projects for GATC DB Care IRVINE, Calif.–(BUSINESS

ERS Genomics and NUVISAN ICB Sign CRISPR/Cas9 License Agreement

BioTech 365

Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China

BioTech 365

Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China Incyte and InnoCare Announce Collaboration and License Agreement for Tafasitamab in Greater China WILMINGTON, Del. &

EssilorLuxottica : EssilorLuxottica and Coach renew global license agreement

BioTech 365

EssilorLuxottica : EssilorLuxottica and Coach renew global license agreement EssilorLuxottica : EssilorLuxottica and Coach renew global license agreement EssilorLuxottica and Coach renew global license agreement Charenton-le-Pont, France and New York, US (June 25, 2021 – 8:00 am CEST) – EssilorLuxottica … Continue reading → GlobeNewswire

Avacta Announces License Agreement With POINT Biopharma Inc.

BioTech 365

Avacta Announces License Agreement With POINT Biopharma Inc. Avacta Announces License Agreement With POINT Biopharma Inc.

Avacta Group plc Signs License Agreement With Astrea Bioseparations

BioTech 365

Vifor Licenses Rare Kidney Disease Drug in Comeback for Travere

BioSpace

Vifor Pharma Group and Travere Therapeutics inked a collaborationfor the commercialization of sparsentan for the treatment rare progressive kidney diseases

ERS Genomics and Setsuro Tech Sign CRISPR/Cas9 License Agreement

BioTech 365